Chr. Hansen Expands Production Facilities For Probiotics

Drinking yoghurt_highweb.jpg

19 Feb 2013 --- A new freeze-drying plant for probiotic cultures for dietary supplements is in the making in Denmark. A new market analysis predicts the global probiotics market to surge by 6.8% a year until 2018, driven by Asia-Pacific with Europe as another dominant market in spite of current health claim law issues (source: The Global Industry Analysis).

--- In sales terms this corresponds to USD 27.9 billion in 2011, forecast to reach US$44.9 bn in 2018.

The increasing culture sales, both in terms of probiotics and food cultures, puts pressure on Chr. Hansen’s production facilities and in order to sustain the growing customer demand the global bioscience company is investing in expanding its capacity.

“Over the past years we have worked to turn our production facility at Roskilde south of Copenhagen into a dedicated production site for human health products, both to live up to pharma GMPs and to free capacity at our food culture production site in Copenhagen,” says Henrik Dalboege, Executive Vice President, Human Health & Nutrition Division, Chr. Hansen.

“We started the construction work on the new freeze-drying plant just before Christmas and I am very pleased to see this project progressing as planned. It is an important element in sustaining the current and future growth of the Human Health & Nutrition Division and its contribution to the entire group”.

The lay-out of the new plant ensures that visitors can observe and inspect the main operations and equipment during the production process. Customers will encounter a state-of-the-art production facility with a high level of hygienic design of both clean rooms and production equipment.

Furthermore the new plant is designed to improve working conditions and with the use of 1:1 models of different work stations it has been designed and pre-approved according to occupational health and safety standards before the construction work was started. Additional benefits are new modern offices and a new maintenance workshop.

Once finished in spring 2014 it will be the world’s largest freeze-drying plant for pharmaceutical grade probiotic cultures.

Related Articles

Nutrition & Health News

Research driving demand for OPO in China’s formula market: Advanced Lipids

16 Feb 2018 --- OPO is increasing in popularity in China’s infant formula market, and according to Advanced Lipids, this is down to the growing body of scientific research backing the benefits of this ingredient. Also known as SN-2 palmitate, OPO is a premium quality ingredient that mimics the fatty acid profile of human milk.

Nutrition & Health News

Vegan diet improves diabetes markers in overweight adults: study

16 Feb 2018 --- A plant-based diet improves beta-cell function and insulin sensitivity in overweight adults with no history of diabetes, according to a new study published in Nutrients by researchers from the Physicians Committee for Responsible Medicine. Measuring the function of beta cells, which store and release insulin, can help assess future type 2 diabetes risk.

Nutrition & Health News

Lactose-free dairy: DSM to market cost-effective analyzer

16 Feb 2018 --- February 2018, DSM will exclusively market BIOMILK 300, a compact residual lactose-analyzing device produced by Biolan. For dairy producers, the BIOMILK 300 is a fast, cost-effective and accurate analyzer for quantifying residual lactose levels in lactose-free and lactose-reduced dairy products.

Nutrition & Health News

A gold medal for recovery? FrieslandCampina DMV develops innovative casein isolate 

14 Feb 2018 --- FrieslandCampina DMV has introduced their latest innovation in dairy protein ingredients. Micelate Prestige has been launched this week in Europe and is a key addition to the company’s growing portfolio of Performance Nutrition solutions. 

Nutrition & Health News

Clear definition and regulations needed to tap into nutraceuticals’ potential: review

13 Feb 2018 --- Nutraceuticals with health benefits substantiated by clinical data can be powerful tools to prevent and treat medical conditions, especially in individuals who may not yet be eligible for conventional pharmaceutical drugs. However, there is a clear need for clear regulations to ensure their safety. This is according to a review published in the British Journal of Clinical Pharmacology, which further proposes a clear definition for this type of product. 

More Articles
URL : http://www.nutritioninsight.com:80/news/Chr-Hansen-Expands-Production-Facilities-For-Probiotics.html